123 related articles for article (PubMed ID: 21787324)
1. The amyloid cascade hypothesis has misled the pharmaceutical industry.
Biochem Soc Trans; 2011 Aug; 39(4):920-3. PubMed ID: 21787324
[TBL] [Abstract][Full Text] [Related]
2. Alzheimer's disease amyloid hypothesis at crossroads: where do we go from here?
Saxena U
Expert Opin Ther Targets; 2010 Dec; 14(12):1273-7. PubMed ID: 21058918
[TBL] [Abstract][Full Text] [Related]
3. Design and evaluation of a 6-mer amyloid-beta protein derived phage display library for molecular targeting of amyloid plaques in Alzheimer's disease: Comparison with two cyclic heptapeptides derived from a randomized phage display library.
Larbanoix L; Burtea C; Ansciaux E; Laurent S; Mahieu I; Vander Elst L; Muller RN
Peptides; 2011 Jun; 32(6):1232-43. PubMed ID: 21575663
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy for Alzheimer's disease.
Solomon B; Frenkel D
Neuropharmacology; 2010; 59(4-5):303-9. PubMed ID: 20388523
[TBL] [Abstract][Full Text] [Related]
5. Accumulation of cellular prion protein within dystrophic neurites of amyloid plaques in the Alzheimer's disease brain.
Takahashi RH; Tobiume M; Sato Y; Sata T; Gouras GK; Takahashi H
Neuropathology; 2011 Jun; 31(3):208-14. PubMed ID: 21062360
[TBL] [Abstract][Full Text] [Related]
6. Lipid oxidation and modification of amyloid-β (Aβ) in vitro and in vivo.
Ellis G; Fang E; Maheshwari M; Roltsch E; Holcomb L; Zimmer D; Martinez D; Murray IV
J Alzheimers Dis; 2010; 22(2):593-607. PubMed ID: 20847409
[TBL] [Abstract][Full Text] [Related]
7. Genetically augmenting tau levels does not modulate the onset or progression of Abeta pathology in transgenic mice.
Oddo S; Caccamo A; Cheng D; Jouleh B; Torp R; LaFerla FM
J Neurochem; 2007 Aug; 102(4):1053-63. PubMed ID: 17472708
[TBL] [Abstract][Full Text] [Related]
8. Effects of sex hormones on Alzheimer's disease-associated β-amyloid oligomer formation in vitro.
Morinaga A; Ono K; Takasaki J; Ikeda T; Hirohata M; Yamada M
Exp Neurol; 2011 Apr; 228(2):298-302. PubMed ID: 21281631
[TBL] [Abstract][Full Text] [Related]
9. γ-Secretase component presenilin is important for microglia β-amyloid clearance.
Farfara D; Trudler D; Segev-Amzaleg N; Galron R; Stein R; Frenkel D
Ann Neurol; 2011 Jan; 69(1):170-80. PubMed ID: 21280087
[TBL] [Abstract][Full Text] [Related]
10. Amelioration of the Alzheimer's disease phenotype by absence of 12/15-lipoxygenase.
Yang H; Zhuo JM; Chu J; Chinnici C; Praticò D
Biol Psychiatry; 2010 Nov; 68(10):922-9. PubMed ID: 20570249
[TBL] [Abstract][Full Text] [Related]
11. Strategies, development, and pitfalls of therapeutic options for Alzheimer's disease.
Haas C
J Alzheimers Dis; 2012; 28(2):241-81. PubMed ID: 21987594
[TBL] [Abstract][Full Text] [Related]
12. Alzheimer's disease 2012: the great amyloid gamble.
Marchesi VT
Am J Pathol; 2012 May; 180(5):1762-7. PubMed ID: 22472273
[TBL] [Abstract][Full Text] [Related]
13. Progress in Alzheimer's disease drug discovery: an update.
Williams M
Curr Opin Investig Drugs; 2009 Jan; 10(1):23-34. PubMed ID: 19127484
[TBL] [Abstract][Full Text] [Related]
14. Alzheimer's disease: from pathology to therapeutic approaches.
Jakob-Roetne R; Jacobsen H
Angew Chem Int Ed Engl; 2009; 48(17):3030-59. PubMed ID: 19330877
[TBL] [Abstract][Full Text] [Related]
15. [Curative treatment of Alzheimer's disease is still missing--is amyloid plaque hypothesis the wrong starting point?].
Tanila H
Duodecim; 2015; 131(3):243-8. PubMed ID: 26245074
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacotherapy for the treatment of Alzheimer's disease--the present state and the development in the future].
Yamaguchi N; Okada N; Sugiyama T
Nihon Rinsho; 2002 Jan; 60(1):107-11. PubMed ID: 11808319
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of amyloid formation: a strategy to delay the onset of Alzheimer's disease.
Lansbury PT
Curr Opin Chem Biol; 1997 Aug; 1(2):260-7. PubMed ID: 9667848
[TBL] [Abstract][Full Text] [Related]
18. Genentech's Alzheimer's antibody trial to study disease prevention.
Garber K
Nat Biotechnol; 2012 Aug; 30(8):731-2. PubMed ID: 22871696
[No Abstract] [Full Text] [Related]
19. Alzheimer's Disease Mechanisms and Emerging Roads to Novel Therapeutics.
Sala Frigerio C; De Strooper B
Annu Rev Neurosci; 2016 Jul; 39():57-79. PubMed ID: 27050320
[TBL] [Abstract][Full Text] [Related]
20. Drug development in dementia.
Cunningham EL; Passmore AP
Maturitas; 2013 Nov; 76(3):260-6. PubMed ID: 23707728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
